Company intelligence / Profile preview

FLUIDDA

Kontich, Flanders, Belgiumfluidda.com ↗

Ownership: Private
Employees: ~61
Development stage: Commercial

Overview

FLUIDDA’s Functional Respiratory Imaging technology has been used in over 80 clinical studies to provide sensitive imaging biomarkers for diagnosis and monitoring of respiratory diseases. The company’s FRI platform supports drug development by enabling more precise patient stratification and early detection of treatment effects. Their FDA-cleared Broncholab device aids in diagnostic support for complex respiratory cases.

Therapeutic areas: PulmonologyCardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Medical Imaging

Partnerships

OSIC (Open Source Imaging Consortium)Cereno Scientific—collaboration on advanced imaging in PAH trialsMultiple pharmaceutical companies as CRO clients

Beyond the preview

Go deeper on FLUIDDA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FLUIDDA.

Explore the full profile